Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2019

Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2019

Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2019, provides an overview of Continuous Glucose Monitoring Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Continuous Glucose Monitoring Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Continuous Glucose Monitoring Systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Continuous Glucose Monitoring Systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Continuous Glucose Monitoring Systems under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


  • Introduction
    • Continuous Glucose Monitoring Systems Overview
  • Products under Development
    • Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development
      • Table Figure 1: Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development
      • Table Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development
    • Continuous Glucose Monitoring Systems - Pipeline Products by Territory
      • Table Figure 2: Continuous Glucose Monitoring Systems - Pipeline Products by Territory
      • Table Continuous Glucose Monitoring Systems - Pipeline Products by Territory
    • Continuous Glucose Monitoring Systems - Pipeline Products by Regulatory Path
      • Table Figure 3: Continuous Glucose Monitoring Systems - Pipeline Products by Regulatory Path
      • Table Continuous Glucose Monitoring Systems - Pipeline Products by Regulatory Path
    • Continuous Glucose Monitoring Systems - Pipeline Products by Estimated Approval Date
      • Table Figure 4: Continuous Glucose Monitoring Systems - Pipeline Products by Estimated Approval Date
      • Table Continuous Glucose Monitoring Systems - Pipeline Products by Estimated Approval Date
    • Continuous Glucose Monitoring Systems - Ongoing Clinical Trials
      • Table Figure 5: Continuous Glucose Monitoring Systems - Ongoing Clinical Trials
      • Table Continuous Glucose Monitoring Systems - Ongoing Clinical Trials
  • Continuous Glucose Monitoring Systems - Pipeline Products under Development by Companies
    • Continuous Glucose Monitoring Systems Companies - Pipeline Products by Stage of Development
      • Table Continuous Glucose Monitoring Systems Companies - Pipeline Products by Stage of Development
    • Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development
      • Table Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Under Development
  • Continuous Glucose Monitoring Systems Companies and Product Overview
    • A. Menarini Diagnostics Srl Company Overview
      • A. Menarini Diagnostics Srl Pipeline Products & Ongoing Clinical Trials Overview
        • Table A. Menarini Diagnostics Srl Pipeline Products & Ongoing Clinical Trials Overview
        • Table GlucoMen Day - Product Status
        • Table GlucoMen Day - Product Description
    • Abbott Diabetes Care Inc Company Overview
      • Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table FreeStyle Libre Flash Glucose Monitoring System - Children - Product Status
        • Table FreeStyle Libre Flash Glucose Monitoring System - Children - Product Description
        • Table FreeStyle Libre Glucose Monitoring System - Consumer Version - Product Status
        • Table FreeStyle Libre Glucose Monitoring System - Consumer Version - Product Description
        • Table Abbott Diabetes Care Inc - Ongoing Clinical Trials Overview
        • Table FreeStyle Libre Flash Glucose Monitoring System - Children - A Comparative Study on the Accuracycand Usability Between the Dexcom G5 Mobile CGM System and the FreeStyle Flash Glucose Monitoring System
        • Table FreeStyle Libre Flash Glucose Monitoring System - Children - An Evaluation of the Usability, Skin Reactions and Accuracy of the FreeStyle Libre Flash Glucose Monitoring System
        • Table FreeStyle Libre Flash Glucose Monitoring System - Children - FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients
        • Table FreeStyle Libre Flash Glucose Monitoring System - Children - Individualized Carbohydrate Intake Strategy to Improve Blood Glucose Control During Team Sports in Children and Adolescents with Type 1 Diabetes: A Carowanis Camp Study
        • Table FreeStyle Libre Flash Glucose Monitoring System - Children - Patients Perceptions of Using the Libre System Compared with Conventional SMBG in Adolescents with Type 1 Diabetes the Libre Sat Trial
        • Table FreeStyle Libre Flash Glucose Monitoring System - Children - Prediction and Prevention of Nocturnal Hypoglycemia in Persons with Type 1 Diabetes with Multiple Doses of Insulin using Machine Learning Techniques
    • Advanced Biosensors-Ohio LLC (Inactive) Company Overview
      • Advanced Biosensors-Ohio LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Advanced Biosensors-Ohio LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table My Medibit - Product Status
        • Table My Medibit - Product Description
    • Advanced Medical Electronics Corp Company Overview
      • Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Continuous Glucose Monitor - Product Status
        • Table Continuous Glucose Monitor - Product Description
    • Arkal Medical, Inc. (Inactive) Company Overview
      • Arkal Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Arkal Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table GlucoPod CGM System - Product Status
        • Table GlucoPod CGM System - Product Description
    • Ascensia Diabetes Care Holdings AG Company Overview
      • Ascensia Diabetes Care Holdings AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ascensia Diabetes Care Holdings AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table CONTOUR PLUS ONE - Product Status
        • Table CONTOUR PLUS ONE - Product Description
    • Azurite Technologies, Inc. (Inactive) Company Overview
      • Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Blood Glucose Sensor - Product Status
        • Table Blood Glucose Sensor - Product Description
    • Biorasis Inc Company Overview
      • Biorasis Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biorasis Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Glucowizzard - Product Status
        • Table Glucowizzard - Product Description
    • Biovotion AG Company Overview
      • Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table VSM 3 Glucose Monitoring System - Product Status
        • Table VSM 3 Glucose Monitoring System - Product Description
    • Brigham and Women's Hospital Company Overview
      • Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fluorescence Measurement Device - Product Status
        • Table Fluorescence Measurement Device - Product Description
    • CALISTO MEDICAL, INC. (Inactive) Company Overview
      • CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Glucoband - Product Status
        • Table Glucoband - Product Description
    • CGM3 Ltd Company Overview
      • CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Miniaturized Implantable Continuous Glucose Monitor - Product Status
        • Table Miniaturized Implantable Continuous Glucose Monitor - Product Description
    • City, University of London Company Overview
      • City, University of London Pipeline Products & Ongoing Clinical Trials Overview
        • Table City, University of London Pipeline Products & Ongoing Clinical Trials Overview
        • Table Non-Invasive Glucose Monitor - Product Status
        • Table Non-Invasive Glucose Monitor - Product Description
    • Columbia University Company Overview
      • Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Wearable Continuous Blood Glucose Monitoring Device - Product Status
        • Table Wearable Continuous Blood Glucose Monitoring Device - Product Description
    • ConvaTec Group Plc Company Overview
      • ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Closed Loop Continuous Glucose Monitoring System - Product Status
        • Table Closed Loop Continuous Glucose Monitoring System - Product Description
    • Cyber Medical Ltd Company Overview
      • Cyber Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cyber Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cybersensors Continuous Glucose Sensor - Product Status
        • Table Cybersensors Continuous Glucose Sensor - Product Description
    • Debiotech SA Company Overview
      • Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Integrated iSense CGM And JewelPUMP - Product Status
        • Table Integrated iSense CGM And JewelPUMP - Product Description
    • DexCom Inc Company Overview
      • DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dexcom G6 CGM System - Product Status
        • Table Dexcom G6 CGM System - Product Description
        • Table Dexcom G7 CGM System - Product Status
        • Table Dexcom G7 CGM System - Product Description
        • Table First-Gen Verily Sensor - Product Status
        • Table First-Gen Verily Sensor - Product Description
        • Table DexCom Inc - Ongoing Clinical Trials Overview
        • Table Dexcom G6 CGM System - A Randomized Cross-over Clinical Trial to Assess the Efficacy of Closedloop Control (CLC) and Predictive Low-glucose Suspend (PLGS) Compared with Sensor-augmented Pump Therapy (SAP) Among Older Adults with Type 1 Diabetes
        • Table Dexcom G6 CGM System - An Extension Study of t:Slim X2 with Control-IQ Technology
        • Table Dexcom G6 CGM System - An Observational Study of Individuals with Type 1 Diabetes Using the Loop System for Automated Insulin Delivery
        • Table Dexcom G6 CGM System - An Open-label, Multi-center, Multi-national, Randomized, 2-period Crossover Study to Assess the Efficacy, Safety and Utility of Closed Loop Insulin Delivery in Comparison with Sensor Augmented Pump Therapy Over 4 Months in Children With Type 1 Diabetes Aged 1 to 7 Years in the Home Setting
        • Table Dexcom G6 CGM System - An Open-label, Three-center, Randomized, Two-session, Crossover Study, to Assess 4 Days Inpatient, and 6-week Follow-up Home Study Phase under Remote Monitoring at Only French Centers, the Efficacy and the Safety of the Diabeloop Closed-loop Glucose Control Compared with Sensor-augmented Pump Therapy, in Young Children with Type 1 Diabetes
        • Table Dexcom G6 CGM System - Assessment of the Accuracy of Continuous Glucose Sensors in People with Diabetes Undergoing Haemodialysis
        • Table Dexcom G6 CGM System - Continuous Glucose Monitoring (CGM) in Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE)
        • Table Dexcom G6 CGM System - Continuous Glucose Monitoring During and after Surgery
        • Table Dexcom G6 CGM System - Data Acquisition to Model Glycemic Response to Food and Other Events Using Real-Time Continuous Glucose Monitoring (RT-CGM)
        • Table Dexcom G6 CGM System - Empowering Medicare Patients to Self-Manage Their Type 2 Diabetes Using Continuous Glucose Monitoring (CGM) - Investigational Device Pilot (SMA Investigational Device)
        • Table Dexcom G6 CGM System - Hypoglycemia Reduction with Automated-insulin Delivery System: The VRIF Trial
        • Table Dexcom G6 CGM System - Inpatient and Post-hospital Discharge Assessment of Glycemic Control by Capillary Point-of-care Glucose Testing and by Continuous Glucose Monitoring in Insulin-treated Patients With Type 1 and Type 2 Diabetes: Dexcom G6 Observational Study
        • Table Dexcom G6 CGM System - Integrated Analysis of the Interactions Between Glycemia and Microbiota Composition, and their Impact on Brain Iron Deposition and Cognition in Subjects with Obesity
        • Table Dexcom G6 CGM System - Observational Study of Patient Important Outcomes in Pregnant Patients with Type 1 Diabetes Mellitus on Insulin Pump
        • Table Dexcom G6 CGM System - Performance of the Dexcom G6 Continuous Glucose Monitoring (CGM) System in Pregnant Women with Diabetes Mellitus
        • Table Dexcom G6 CGM System - Perioperative Continuous Glucose Monitoring in Patients Undergoing an Abdominal Surgery - An Observational Study
        • Table Dexcom G6 CGM System - The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas in Pediatrics: A Study of t:Slim X2 with Control-IQ Technology
        • Table Dexcom G6 CGM System - The Technological Challenge of Continuous Wireless Monitoring in Internal Medicine Unit to Improve Management of Complex Patients: the Green Line from Hospital to Territory (Green Line H-T Study)
        • Table Dexcom G6 CGM System - Wireless Innovation for Seniors with Diabetes Mellitus: WISDM
        • Table Dexcom G7 CGM System - Empowering Medicare Patients to Self-Manage Their Type 2 Diabetes Using Continuous Glucose Monitoring (CGM) - Investigational Device Pilot (SMA Investigational Device)
    • DirectSens GmbH Company Overview
      • DirectSens GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table DirectSens GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3rd Generation Glucose Sensor - Product Status
        • Table 3rd Generation Glucose Sensor - Product Description
        • Table Continuous Blood Glucose Monitoring System - Product Status
        • Table Continuous Blood Glucose Monitoring System - Product Description
    • Echo Therapeutics Inc Company Overview
      • Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gen 2 Symphony CGM System - Product Status
        • Table Gen 2 Symphony CGM System - Product Description
        • Table NextGen System - Product Status
        • Table NextGen System - Product Description
        • Table Symphony tCGM System - Home - Product Status
        • Table Symphony tCGM System - Home - Product Description
        • Table Symphony tCGM System - Hospital Critical Care - Product Status
        • Table Symphony tCGM System - Hospital Critical Care - Product Description
    • Ecole Polytechnique Federale de Lausanne Company Overview
      • Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview
        • Table Viscosimetric Glucose Sensor - Product Status
        • Table Viscosimetric Glucose Sensor - Product Description
    • eLutions Integrated Systems, Inc. Company Overview
      • eLutions Integrated Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table eLutions Integrated Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Optically-Efficient Miniaturized Raman Optical System - Product Status
        • Table Optically-Efficient Miniaturized Raman Optical System - Product Description
    • EyeSense GmbH Company Overview
      • EyeSense GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table EyeSense GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table FiberSense System - Product Status
        • Table FiberSense System - Product Description
        • Table EyeSense GmbH - Ongoing Clinical Trials Overview
        • Table FiberSense System - Effectiveness and Safety Study of the Percutaneous Optical Fibre Glucose Sensor (FiberSense) for Home Use in Diabetic and Prediabetic Individuals
    • Flowsion A/S Company Overview
      • Flowsion A/S Pipeline Products & Ongoing Clinical Trials Overview
        • Table Flowsion A/S Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diramo System - Product Status
        • Table Diramo System - Product Description
        • Table Glycostat - Product Status
        • Table Glycostat - Product Description
    • Gili Medical Ltd Company Overview
      • Gili Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gili Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diawatch - Product Status
        • Table Diawatch - Product Description
    • Globe Medical Tech Inc (Inactive) Company Overview
      • Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Continuous Glucose Monitoring Device - Product Status
        • Table Continuous Glucose Monitoring Device - Product Description
    • GlucoLight Corporation (Inactive) Company Overview
      • GlucoLight Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table GlucoLight Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table SENTRIS-100 - Product Status
        • Table SENTRIS-100 - Product Description
    • Glucometrix AG Company Overview
      • Glucometrix AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Glucometrix AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Non-Invasive Blood Glucose Monitoring Device - Product Status
        • Table Non-Invasive Blood Glucose Monitoring Device - Product Description
    • Glucosense Diagnostics Ltd (Inactive) Company Overview
      • Glucosense Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Glucosense Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Non-Invasive Blood Glucose Monitor - Product Status
        • Table Non-Invasive Blood Glucose Monitor - Product Description
    • GlucoSet AS Company Overview
      • GlucoSet AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table GlucoSet AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table GlucoSet Sensor - Product Status
        • Table GlucoSet Sensor - Product Description
    • Glucovation Inc Company Overview
      • Glucovation Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Glucovation Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SugarSenz Continuous Glucose Monitor - Product Status
        • Table SugarSenz Continuous Glucose Monitor - Product Description
    • GluMetrics Inc Company Overview
      • GluMetrics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GluMetrics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GluCath Intravascular Continuous Glucose Monitor - Product Status
        • Table GluCath Intravascular Continuous Glucose Monitor - Product Description
    • Glusense Ltd Company Overview
      • Glusense Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Glusense Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Glyde CGM - Product Status
        • Table Glyde CGM - Product Description
    • GlySens Inc Company Overview
      • GlySens Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GlySens Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eclipse ICGM System - Product Status
        • Table Eclipse ICGM System - Product Description
        • Table Second Generation ICGM System - Product Status
        • Table Second Generation ICGM System - Product Description
        • Table GlySens Inc - Ongoing Clinical Trials Overview
        • Table Eclipse ICGM System - Accuracy of Long-term Implantable Glucose Monitoring in Type 1 Diabetes
        • Table Eclipse ICGM System - Function of Implanted Glucose Sensor - High Definition Trial in Type 1 diabetes
    • G-Sense Ltd. Company Overview
      • G-Sense Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table G-Sense Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table G-Sense Device - Product Status
        • Table G-Sense Device - Product Description
    • iGlyko, Inc. (Inactive) Company Overview
      • iGlyko, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table iGlyko, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table iGlyko System - Product Status
        • Table iGlyko System - Product Description
    • Indigo Diabetes NV Company Overview
      • Indigo Diabetes NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Indigo Diabetes NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Needle-Free Glucose Sensor - Product Status
        • Table Needle-Free Glucose Sensor - Product Description
    • Innovosens AB Company Overview
      • Innovosens AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Innovosens AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diabsens - Product Status
        • Table Diabsens - Product Description
    • Insulet Corp Company Overview
      • Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Integrated CGM With Next Gen OmniPod System PDM - Product Status
        • Table Integrated CGM With Next Gen OmniPod System PDM - Product Description
    • Integrated Medical Sensors Company Overview
      • Integrated Medical Sensors Pipeline Products & Ongoing Clinical Trials Overview
        • Table Integrated Medical Sensors Pipeline Products & Ongoing Clinical Trials Overview
        • Table Implantable Continuous Glucose Monitor - Product Status
        • Table Implantable Continuous Glucose Monitor - Product Description
    • Integrity Applications Ltd Company Overview
      • Integrity Applications Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Integrity Applications Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table GlucoTrack - DF-C - Product Status
        • Table GlucoTrack - DF-C - Product Description
        • Table GlucoTrack DF-F - Product Status
        • Table GlucoTrack DF-F - Product Description
        • Table GlucoTrack DF-F - Pre-diabetes - Product Status
        • Table GlucoTrack DF-F - Pre-diabetes - Product Description
        • Table Integrity Applications Ltd - Ongoing Clinical Trials Overview
        • Table GlucoTrack DF-F - A Customer Experience Program of GlucoTrack in Patients Diagnosed with Type II Diabetes in Netherlands
    • Invivosense ASA (Inactive) Company Overview
      • Invivosense ASA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Invivosense ASA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table IvSCGM Biosensor - Product Status
        • Table IvSCGM Biosensor - Product Description
    • I-Sens Inc Company Overview
      • I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sens Inc Continuous Glucose Monitor - Product Status
        • Table Sens Inc Continuous Glucose Monitor - Product Description
    • iSense Corporation (Inactive) Company Overview
      • iSense Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table iSense Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table iSense CGM - Product Status
        • Table iSense CGM - Product Description
    • Keratin Biosciences Inc Company Overview
      • Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Illume - Product Status
        • Table Illume - Product Description
    • Know Labs Inc Company Overview
      • Know Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Know Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table UBAND - Product Status
        • Table UBAND - Product Description
    • KTH Royal Institute of Technology Company Overview
      • KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microneedle Patch - Glucose Monitoring - Product Status
        • Table Microneedle Patch - Glucose Monitoring - Product Description
    • LEMM Technologies, LLC Company Overview
      • LEMM Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table LEMM Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table LEMM Technologies, LLC Non-Invasive Blood Glucose Monitor - Product Status
        • Table LEMM Technologies, LLC Non-Invasive Blood Glucose Monitor - Product Description
    • Massachusetts Institute of Technology Company Overview
      • Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Glucose Sensitive Tattoo - Product Status
        • Table Glucose Sensitive Tattoo - Product Description
        • Table Implantable Glucose Sensor - Product Status
        • Table Implantable Glucose Sensor - Product Description
    • Medical Wireless Sensing Ltd Company Overview
      • Medical Wireless Sensing Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medical Wireless Sensing Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table GlucoWiSe - Product Status
        • Table GlucoWiSe - Product Description
    • Medtronic Diabetes Company Overview
      • Medtronic Diabetes Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medtronic Diabetes Pipeline Products & Ongoing Clinical Trials Overview
        • Table Combo Set Glucose Monitoring System - Product Status
        • Table Combo Set Glucose Monitoring System - Product Description
        • Table Enhanced Enlite Glucose Sensor - Product Status
        • Table Enhanced Enlite Glucose Sensor - Product Description
        • Table Guardian Connect Mobile CGM System - Product Status
        • Table Guardian Connect Mobile CGM System - Product Description
        • Table Harmony 1 Sensor - Product Status
        • Table Harmony 1 Sensor - Product Description
        • Table Harmony 2 Sensor - Product Status
        • Table Harmony 2 Sensor - Product Description
        • Table iPro 3 Glucose Monitoring System - Product Status
        • Table iPro 3 Glucose Monitoring System - Product Description
        • Table ipro 4 Glucose Monitoring System - Product Status
        • Table ipro 4 Glucose Monitoring System - Product Description
        • Table ipro 5 Glucose Monitoring System Sensor - Product Status
        • Table ipro 5 Glucose Monitoring System Sensor - Product Description
        • Table Synergy Sensor - Product Status
        • Table Synergy Sensor - Product Description
        • Table Medtronic Diabetes - Ongoing Clinical Trials Overview
        • Table iPro 3 Glucose Monitoring System - Restoring Brain Metabolism and Function in Older Adult T1DM Patients Using an AP System
        • Table ipro 5 Glucose Monitoring System Sensor - Restoring Brain Metabolism and Function in Older Adult T1DM Patients Using an AP System
        • Table ipro 4 Glucose Monitoring System - Restoring Brain Metabolism and Function in Older Adult T1DM Patients Using an AP System
    • Medtronic plc Company Overview
      • Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zeus Next Generation Guardian Sensor - Product Status
        • Table Zeus Next Generation Guardian Sensor - Product Description
    • Mellitor Ltd Company Overview
      • Mellitor Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mellitor Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mellitor Sensor - Product Status
        • Table Mellitor Sensor - Product Description
    • Metronom Health Inc Company Overview
      • Metronom Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Metronom Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CGM System - Product Status
        • Table CGM System - Product Description
        • Table Metronom Health Inc - Ongoing Clinical Trials Overview
        • Table CGM System - Evaluation of Different Types of Adhesive Materials for Continuous Glucose Monitoring Systems in Subjects with Type 1 and Type 2 Diabetes Mellitus
    • mobiLIFE Company Overview
      • mobiLIFE Pipeline Products & Ongoing Clinical Trials Overview
        • Table mobiLIFE Pipeline Products & Ongoing Clinical Trials Overview
        • Table GlucoReader - Product Status
        • Table GlucoReader - Product Description
    • Nemaura Medical Inc Company Overview
      • Nemaura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nemaura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table sugarBEAT - Product Status
        • Table sugarBEAT - Product Description
    • Newton Photonics Inc Company Overview
      • Newton Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Newton Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Newton Photonics Inc Non-invasive Blood Glucose Monitor - Product Status
        • Table Newton Photonics Inc Non-invasive Blood Glucose Monitor - Product Description
    • Northwestern University Company Overview
      • Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Continuous Glucose Sensor - Product Status
        • Table Continuous Glucose Sensor - Product Description
    • Orsus Medical Ltd Company Overview
      • Orsus Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Orsus Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Orsus Medical Ltd Non-Invasive Blood Glucose Monitor - Product Status
        • Table Orsus Medical Ltd Non-Invasive Blood Glucose Monitor - Product Description
    • PKvitality Company Overview
      • PKvitality Pipeline Products & Ongoing Clinical Trials Overview
        • Table PKvitality Pipeline Products & Ongoing Clinical Trials Overview
        • Table K'Watch Glucose - Product Status
        • Table K'Watch Glucose - Product Description
    • PositiveID Corp Company Overview
      • PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fully Synthetic Glucose Sensing System - Product Status
        • Table Fully Synthetic Glucose Sensing System - Product Description
    • Prediktor Medical AS Company Overview
      • Prediktor Medical AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prediktor Medical AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioMKR one - Product Status
        • Table BioMKR one - Product Description
    • Profusa Inc Company Overview
      • Profusa Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Profusa Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Non-enzymatic Glucose Sensor - Product Status
        • Table Non-enzymatic Glucose Sensor - Product Description
    • Purdue University Company Overview
      • Purdue University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Purdue University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Soft Contact Lens - Glucose Monitoring - Product Status
        • Table Soft Contact Lens - Glucose Monitoring - Product Description
    • San Meditech (Huzhou) Co., Ltd. Company Overview
      • San Meditech (Huzhou) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table San Meditech (Huzhou) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dynamic Glucose Monitoring System - Product Status
        • Table Dynamic Glucose Monitoring System - Product Description
    • Senseonics Holdings Inc Company Overview
      • Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eversense XL CGM System - Product Status
        • Table Eversense XL CGM System - Product Description
        • Table Senseonics Holdings Inc - Ongoing Clinical Trials Overview
        • Table Eversense XL CGM System - Benefits of a Long Term Implantable Continuous Glucose Monitoring System for Adults with Diabetes - France Randomized Clinical Trial
        • Table Eversense XL CGM System - PROMISE Study: A Prospective, Multicenter Evaluation of Accuracy and Safety of an Implantable Continuous Glucose Sensor Lasting up to 180 Days
    • SensiVida Medical Technologies, Inc. (Inactive) Company Overview
      • SensiVida Medical Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table SensiVida Medical Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Glucose Monitoring System - Product Status
        • Table Glucose Monitoring System - Product Description
    • Senzime AB Company Overview
      • Senzime AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Senzime AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table CliniSenz - Product Status
        • Table CliniSenz - Product Description
    • Singapore Biomicro Pte Ltd Company Overview
      • Singapore Biomicro Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Singapore Biomicro Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Implantable Blood Glucose Monitoring Device - Product Status
        • Table Implantable Blood Glucose Monitoring Device - Product Description
    • Socrates Health Solutions, Inc. Company Overview
      • Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Companion CM - Product Status
        • Table Companion CM - Product Description
    • Stony Brook University Company Overview
      • Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview
        • Table GlucoREAD Patch - Product Status
        • Table GlucoREAD Patch - Product Description
    • Swansea University Company Overview
      • Swansea University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Swansea University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Flash Glucose Monitoring Device - Product Status
        • Table Flash Glucose Monitoring Device - Product Description
        • Table Hi-Tech Diabetes Blood Glucose Monitor - Product Status
        • Table Hi-Tech Diabetes Blood Glucose Monitor - Product Description
    • Tenax Therapeutics Inc Company Overview
      • Tenax Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tenax Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Glucose Biosensor - Product Status
        • Table Glucose Biosensor - Product Description
    • Terumo Corp Company Overview
      • Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table CMOS Image Glucose Sensor - Product Status
        • Table CMOS Image Glucose Sensor - Product Description
        • Table High Accuracy CGM - Product Status
        • Table High Accuracy CGM - Product Description
    • Texas A&M University Company Overview
      • Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Minimally Invasive Glucose Monitoring System - Product Status
        • Table Minimally Invasive Glucose Monitoring System - Product Description
    • Ultradian Diagnostics LLC Company Overview
      • Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biologue - Product Status
        • Table Biologue - Product Description
    • University of California Berkeley Company Overview
      • University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dropsense Continuous Glucose Monitor - Product Status
        • Table Dropsense Continuous Glucose Monitor - Product Description
    • University of California Irvine Company Overview
      • University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview
        • Table Implantable Device - Diabetes Mellitus - Product Status
        • Table Implantable Device - Diabetes Mellitus - Product Description
    • University of California San Diego Company Overview
      • University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
        • Table Glucose Monitoring Tattoo - Product Status
        • Table Glucose Monitoring Tattoo - Product Description
    • University of South Carolina Company Overview
      • University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
        • Table Continuous Glucose Monitoring System - Product Status
        • Table Continuous Glucose Monitoring System - Product Description
    • University of South Florida Company Overview
      • University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table Long Term Silicon Carbide (SiC) RF Antenna - Product Status
        • Table Long Term Silicon Carbide (SiC) RF Antenna - Product Description
    • University of Technology Sydney Company Overview
      • University of Technology Sydney Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Technology Sydney Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hypo Detection System - Product Status
        • Table Hypo Detection System - Product Description
    • University of Texas at Arlington Company Overview
      • University of Texas at Arlington Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Texas at Arlington Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanotechnology Based Glucose Monitoring Device - Product Status
        • Table Nanotechnology Based Glucose Monitoring Device - Product Description
    • VeriTeQ Corporation Company Overview
      • VeriTeQ Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table VeriTeQ Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table GlucoChip - Product Status
        • Table GlucoChip - Product Description
    • Vytrace, Inc. Company Overview
      • Vytrace, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vytrace, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vytrace, Inc. Continuous Glucose Monitoring Device - Product Status
        • Table Vytrace, Inc. Continuous Glucose Monitoring Device - Product Description
    • WaveForm Technologies Inc Company Overview
      • WaveForm Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table WaveForm Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table WaveForm Technologies Inc Continuous Glucose Monitoring System - Product Status
        • Table WaveForm Technologies Inc Continuous Glucose Monitoring System - Product Description
    • Zyvex Corp Company Overview
      • Zyvex Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zyvex Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table GeNI - Product Status
        • Table GeNI - Product Description
  • Continuous Glucose Monitoring Systems- Recent Developments
    • Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health
    • Jul 23, 2019: Edwards Lifesciences reports second quarter results for the year 2019
    • Jul 18, 2019: Nemaura Medical appoints Chris Avery as vice president of global business operations to support global commercial launch of SugarBEAT
    • Jul 17, 2019: Know Labs announces significant pre-clinical progress of uband noninvasive continuous glucose monitor
    • Jul 10, 2019: Nemaura Medical submits de novo 510(k) application for SugarBEAT to the U.S. Food and Drug Administration
    • Jul 08, 2019: Terumo invests 26 Million Euro in new production lines for its Belgian Facility
    • Jun 27, 2019: FDA warns patients and health care providers about potential cybersecurity concerns with certain Medtronic insulin pumps
    • Jun 25, 2019: ConvaTec Group: Board Change
    • Jun 18, 2019: Senzime contracts new CFO
    • Jun 17, 2019: Nemaura provides fiscal 2019 year-end business update
    • Jun 17, 2019: Abbott reports second-quarter 2019 results
    • Jun 11, 2019: Abbott's FreeStyle device helps significantly reduce glucose levels
    • Jun 10, 2019: Real-World data from Guardian Connect and Sugar.IQ reveal improved diabetes outcomes
    • Jun 08, 2019: Pilot Study Shows That Investigational Interconnected Diabetes Management Solution From Ascensia Significantly Reduced HbA1c in People With Type 2 Diabetes
    • Jun 08, 2019: Medtronic initiates pivotal trial for next-generation Guardian Continuous Glucose Monitoring Sensor
    • Jun 07, 2019: Senzime's board member Ulf Lindskog has passed away
    • Jun 06, 2019: Senseonics announces FDA approval for a non-adjunctive indication (Dosing Claim) for the Eversense 90-day CGM System
    • Jun 05, 2019: Senseonics to present real-world, long-term safety data of the First Implantable CGM Sensor at the American Diabetes Association's 79th Scientific Sessions
    • Jun 04, 2019: Medtronic awarded $150M contract from Defense Logistics Agency
    • May 31, 2019: Nemaura gets European approval for SugarBEAT CGM
    • May 23, 2019: Medtronic announces fiscal year and fourth quarter 2019 financial results
    • May 21, 2019: Terumo appoints EU based Subsidiary's Associate as the Newest Terumo Fellow
    • May 16, 2019: Integrity Applications names Robert T. Guest as Senior Advisor
    • May 14, 2019: CFO transition in Senzime
    • May 08, 2019: Senzime's Interim report January - March 2019
    • May 07, 2019: Henry Schein announces first quarter 2019 financial results
    • May 02, 2019: Nemaura announces open-source software for its continuous glucose monitor SugarBEAT
    • May 02, 2019: Insulet celebrates new global headquarters and U.S. manufacturing facility in Acton, MA
    • May 02, 2019: Insulet Reports First Quarter 2019 Revenue of $159.6 Million, an Increase of 29% Year-Over-Year
    • May 01, 2019: Know Labs announces Racer Technology as manufacturing partner
    • Apr 30, 2019: Tandem Diabetes Care announces first quarter 2019 financial results and updated 2019 financial guidance
    • Apr 23, 2019: Nemaura announces successful completion of summative human factors usability study for SugarBEAT
    • Apr 23, 2019: Edwards Lifesciences announces first quarter results
    • Apr 17, 2019: Abbott reports first-quarter 2019 results
    • Apr 16, 2019: Nemaura announces addition of new predictive alert functionality to SugarBEAT
    • Apr 11, 2019: Profusa expands leadership team with Digital Health, Government and Business Development Hires
    • Mar 28, 2019: Nemaura CEO provides update to shareholders
    • Mar 28, 2019: Senzime strengthens the management team within Sales and Marketing
    • Mar 25, 2019: ConvaTec Group names Karim Bitar as Chief Executive Officer
    • Mar 25, 2019: Medtronic launches Medtech Innovation Accelerator in Shanghai
    • Mar 22, 2019: Senseonics launches the Eversense bridge patient access program in the U.S.
    • Mar 19, 2019: Abbott introduces new digital service in India as part of its global a:care program
    • Mar 14, 2019: Patients with Type 1 Diabetes missing out on Glucose Devices
    • Mar 14, 2019: Medtronic names Andrea J. Goldsmith as a new director
    • Mar 12, 2019: Nemaura Medical announces exclusive license and supply agreement for SugarBEAT in the GCC Region
    • Mar 12, 2019: Senseonics Holdings announces Fourth Quarter and Full Year 2018 Financial Results
    • Mar 12, 2019: Callitas Health Announces the Promotion of Joshua Maurice to Vice President of Sales and Business Development
    • Feb 26, 2019: Tandem Diabetes Care announces succession plan for chief executive officer and board of directors
    • Feb 26, 2019: Tandem Diabetes Care announces 2018 financial results and 2019 financial guidance
    • Feb 26, 2019: Terumo to construct new facilities at its Vietnamese factory -15 billion yen investment to strengthen interventional therapeutic related production
    • Feb 25, 2019: Insulet announces fourth quarter 2018 revenue of $164.9 million, up 26% year-over-year, and full year 2018 revenue of $563.8 million, up 22%
    • Feb 22, 2019: Dexcom G6 CGM System receives Health Canada approval
    • Feb 22, 2019: Abbott planning $62M expansion in Columbus, adding 38 jobs
    • Feb 21, 2019: New Real-World Evidence analysis of nearly half a million FreeStyle Libre System users shows higher rates of scanning improves Glucose Control
    • Feb 20, 2019: Henry Schein reports record fourth quarter and full year 2018 financial results
    • Feb 20, 2019: Tandem Diabetes Care appoints new senior vice president to drive expansion of digital health and information technology initiatives
    • Feb 19, 2019: Medtronic reports third quarter financial results
    • Feb 15, 2019: Senzime's year-end bulletin 2018
    • Feb 14, 2019: Senseonics announces partnership with Geo-Med to provide veterans access to Eversense CGM
    • Feb 14, 2019: ConvaTec Group fourth quarter and annual results 2018
    • Feb 12, 2019: Nemaura reports third quarter 2018 financial results
    • Feb 11, 2019: Nemaura announces Dr. Fred Schaebsdau to lead strategy and business development
    • Feb 07, 2019: Nemaura Medical announces grant of U.S. patent for SugarBEAT Glucose Sensing Algorithm
    • Feb 07, 2019: Pia Renaudin joins as new CEO at Senzime
    • Feb 03, 2019: Senseonics announces extension of distribution agreement with Roche Diabetes Care
    • Jan 31, 2019: Reliq Health Technologies announces release of new version of proprietary software platform, iUGO Care v.2019
    • Jan 31, 2019: Edwards Lifesciences reports financial results for the quarter ended December 31, 2018
    • Jan 30, 2019: Senseonics Eversense CGM Sensor receives indication for MRI
    • Jan 29, 2019: Alert to users of FreeStyle Libre flash glucose monitoring system regarding skin reactions to sensor adhesive
    • Jan 28, 2019: Insulet names Corinne Nevinny as board director
    • Jan 23, 2019: Abbott reports 2018 results and issues strong forecast for 2019
    • Jan 22, 2019: Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences
    • Jan 17, 2019: Nemaura Medical Announces Improvement to SugarBEAT Continuous Glucose Monitor
    • Jan 15, 2019: Boston Scientific, Edwards Lifesciences agree to global litigation settlement
    • Jan 09, 2019: Swedish researchers develop `painless' glucose monitoring system
    • Jan 09, 2019: Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare
    • Jan 07, 2019: Insulet names Wayde McMillan as Chief Financial Officer
    • Jan 03, 2019: Senseonics announces first study participant implanted in PROMISE clinical study and the submission of key PMA supplements to the FDA to advance current 90-day product
    • Jan 03, 2019: Adocia Announces a Clinical Trial Evaluating BioChaperone Lispro and Other Rapid-Acting Insulin Analogs Using iLet Bionic Pancreas
    • Jan 03, 2019: Tandem Diabetes Care announces appointment of Rebecca Robertson as board member
    • Dec 18, 2018: Nemaura publishes positive data from Sugarbeat FDA clinical trial
    • Dec 18, 2018: Know Labs CEO Phil Bosua presents overview of the company's technology and product strategy
    • Dec 17, 2018: Mary & Dick Allen Diabetes Center at Hoag First in Orange County to offer new long-term implantable Continuous Glucose Monitoring System
    • Dec 17, 2018: Integrity Applications announces GlucoTrack customer experience program in the Netherlands
    • Dec 12, 2018: Nemaura to present SugarBEAT clinical performance poster at ATTD, Berlin
    • Dec 10, 2018: Medtronic named one of America's Best Corporate Citizens in 2018 by Forbes Magazine
    • Dec 10, 2018: Edwards Lifesciences will hire 370 employees for new facility
    • Dec 06, 2018: Know Labs Announces Laboratory Comparison Tests of Its UBAND Non- Invasive Blood Glucose Technology and Abbott Labs FreeStyle Libre
    • Dec 05, 2018: Edwards Lifesciences outlines growth strategy at annual investor conference 2018
    • Dec 04, 2018: Nemaura successfully completes clinical studies for SugarBEAT FDA De- Novo 510(k) submission
    • Nov 29, 2018: Voluntary announcement - update on the research and development of a novel percutaneous optical fibre continuous glucose sensor
    • Nov 29, 2018: FDA takes steps to advance the safety and accuracy of blood glucose monitors to empower patients with diabetes with reliable tools to manage their health
    • Nov 26, 2018: $100 million to support type 1 diabetes patients in Bonner
    • Nov 26, 2018: UConn Spinout, Biorasis receives $3M from Helmsley Charitable Trust
    • Nov 20, 2018: Medtronic reports financial results of second quarter of fiscal year 2019
    • Nov 08, 2018: Nemaura Medical reports second quarter 2018 financial results
    • Nov 08, 2018: Medtronic delivers significant progress on global corporate citizenship efforts
    • Nov 08, 2018: Senzime's Interim report January - September 2018
    • Nov 07, 2018: Nemaura successfully develops predictive algorithms and alarm functionality for continuous glucose monitor SugarBEAT
    • Nov 06, 2018: Senseonics announces FDA Approval to Expand Eversense CGM Certification to Nurse Practitioners and Physician Assistants
    • Nov 06, 2018: Henry Schein announces third quarter 2018 financial results
    • Nov 05, 2018: GlySens President and CEO William H. Markle to Speak at Upcoming Healthcare Technology Conferences
    • Nov 05, 2018: Study offers recommendations for scaling patient safety initiatives
    • Nov 01, 2018: Insulet reports third quarter 2018 revenue of $151.1 million, up 24% yearover- year, and gross margin over 67%, up 700 basis points
    • Nov 01, 2018: Tandem Diabetes Care reports third quarter 2018 financial results
    • Oct 23, 2018: Edwards Lifesciences reports third quarter results
    • Oct 22, 2018: Nemaura to host investor webinar on October 23rd 2018 to provide update on recent developments
    • Oct 22, 2018: Senseonics announces Aetna's positive coverage decision for Eversense
    • Oct 18, 2018: Dexcom G6 Continuous Glucose Monitoring System will be available to medicare beneficiaries with diabetes in early 2019
    • Oct 17, 2018: Senzime reports from the American Society of Anesthesiologists (ASA) annual meeting in San Francisco, USA
    • Oct 17, 2018: Abbott Reports Third-Quarter 2018 Results
    • Oct 15, 2018: Abbott names Robert B. Ford President, Chief Operating Officer
    • Oct 15, 2018: ConvaTec Group announces retirement of Chief Executive Officer and appointment of Rick Anderson as Chief Executive Officer (Interim)
    • Oct 15, 2018: Henry Schein to showcase new solutions at the American Dental Association Annual Meeting, October 18 - 20, in Honolulu, HI
    • Oct 09, 2018: Integrity Applications Announces Executive Leadership Changes
    • Oct 04, 2018: Ambrosia launches Follow BluCon working with Amazon Alexa to be able to control the glycemic rate when traveling
    • Oct 01, 2018: Abbott's FreeStyle Libre 2, with optional real-time alarms, secures CE Mark for use in Europe
    • Sep 26, 2018: Roche advances its open diabetes management ecosystem by integrating continuous glucose monitoring data to drive personalised therapy decisions
    • Sep 25, 2018: Nemaura reports positive zero finger-stick calibration data for SugarBEAT continuous glucose monitor
    • Sep 18, 2018: Callitas Health Announces Corporate Update
    • Sep 13, 2018: Abbott is named global industry leader in sustainability for the sixth consecutive year on the Dow Jones Sustainability Index (DJSI)
    • Sep 12, 2018: Nemaura reports positive interim data from clinic portion of SugarBEAT FDA clinical trial
    • Sep 10, 2018: Insulet announces Shacey Petrovic, President and COO, promoted to CEO, effective January 1, 2019; Patrick Sullivan will retire as Chairman and CEO at the end of 2018
    • Sep 05, 2018: Livongo becomes first comprehensive Ddabetes offering to add Abbott's FreeStyle Libre Pro System to platform
    • Aug 30, 2018: Lee's Pharmaceutical Holdings: Interim results for the six months ended 30 June 2018
    • Aug 28, 2018: Nemaura Medical strengthens manufacturing team in preparation for SugarBEAT commercial launch
    • Aug 28, 2018: Changes to the Roche Executive Committee
    • Aug 23, 2018: New Chair appointed to Advanced Nuclear Research Centre
    • Aug 22, 2018: Positive Results for Ultradian Diagnostics 5-Day Clinical Study of Biologue CGM
    • Aug 22, 2018: Senzime: Interim report quarter 2, 2018
    • Aug 21, 2018: Medtronic announces first quarter financial results
    • Aug 21, 2018: Henry Schein Named To FORTUNE's 'Change The World' List
    • Aug 16, 2018: President and CEO of Terumo BCT David Perez to Retire after FY 2018 Antoinette Gawin Named as Successor
    • Aug 15, 2018: David Perez to retire as President and CEO of Terumo BCT on March 31, 2019; Antoinette Gawin named successor
    • Aug 14, 2018: Integrity applications receives first order from curatec nordic for Glucotrack
    • Aug 09, 2018: Nemaura Medical reports first quarter 2018 financial results
    • Aug 07, 2018: Senseonics Begins U.S. Commercialization of Eversense Continuous Glucose Monitoring System With First Shipment, First Users and First Policy Coverage
    • Aug 06, 2018: Henry Schein reports record second quarter 2018 financial results
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook